Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that Walter Klemp, Chairman and Chief Executive Officer of Moleculin, participated in a Virtual Investor “What ...

Close to a third of firms inspected by the Solicitors Regulation Authority (SRA) were found non-compliant. AMLCC’s Richard Simms explains what inspectors look for and how to ensure your firm is ready.

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), today announced that Walter Klemp, Chairman and Chief Executive ...

Amgen recalled nearly one million bottles of Corlanor and Sensipar tablets after unexpected foreign matter was found on ...

Both Annamycin dose arms outperformed control on the primary endpoint of complete remission (CR): 43% and 36% versus 12% — ...

The drop follows four straight days of the stock closing in the green.

Good day, everyone. My name is Stefan, and I'll be your conference operator today. At this time, I'd like to welcome you to Kura Oncology's investor call to discuss the long-term results of ziftomenib ...

Corlanor (ivabradine) is used in certain patients with chronic heart failure, and Sensipar (cinacalcet) helps control ...

There is no shortage of theories, from stacks of cash hidden at home to illicit activities, but little in the way of ...

The build-out of a comprehensive regulatory framework for payment stablecoins is steadily moving toward completion, as the various agencies ...